Grant winners

July 4, 2013

Arts and Humanities Research Council

Responsive Mode Grants

  • Award winner: Brian Balmer
  • Institution: University College London
  • Value: £368,357

Understanding biological disarmament: the historical context of the origins of the biological weapons convention

Hit songs and their significance in 17th-century England

In search of Italian cinema audiences in the 1940s and 1950s: gender, genre and national identity

Leverhulme Trust

Research Project Grants
Sciences

The role of motor abilities in the development of typical and atypical social behaviour

Developing in vitro approaches for testing mucoadhesive drug delivery systems

Investigation of the role of 5-HT in psychological responses to affective touch

National Institute for Health Research

Efficacy and Mechanism Evaluation Programme

  • Award winner: J. Chataway
  • Institution: University College London
  • Value: £2,784,701

A multi-arm phase IIb randomised, double-blind clinical trial comparing the efficacy of three neuroprotective drugs compared with placebo in secondary progressive multiple sclerosis

Health Services and Delivery Research Programme

Seclusion and psychiatric intensive care evaluation study

Benefit to patients and the NHS of cardiovascular magnetic resonance imaging after primary percutaneous coronary intervention

Health Technology Assessment Programme

Pressure-relieving support surfaces: a randomised evaluation 2 (PRESSURE 2)

In detail

Medical Research Council – New Investigator Research Grant

Award winner: Diego Gomez‑Nicola
Institution: University of Southampton
Value: £496,917

Regulation of microglial proliferation and its contribution to chronic neurodegeneration

In people with degenerative diseases of the brain such as Alzheimer’s, there is growing evidence that systemic infections or inflammation may accelerate disease progression and exacerbate symptoms. This project aims to better understand the mechanisms that regulate immune-to-brain communication and the progression of chronic neurodegeneration, which could lead to the development of new preventative or therapeutic approaches. “The research is novel and ambitious, and would generate important information for the neuroimmunological and medical sciences community,” said Dr Gomez‑Nicola. “The potential outcomes would be rapidly translated into the clinics of neuropathology and would improve the quality of life of patients with such diseases.”

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Register
Please Login or Register to read this article.

Sponsored

Featured jobs

See all jobs